Lorazepam
- Product NDC
- 60687-649
- 11-digit product format
- 606870649
- Labeler code
- 60687
- Product ID
- 60687-649_e272e14c-637c-4b5f-e053-2a95a90a3a8c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lorazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA072928
- Marketing category
- ANDA
- Marketing start
- 2021-10-07
- Marketing end
- 0000-00-00
- Substance
- LORAZEPAM
- Active strength
- 2 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60687-649 | LORAZEPAM TABLET [AMERICAN HEALTH PACKAGING] | 7 | Legacy NDC | 20240807_5283f007-7703-45d0-ba48-8e63fa586992.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60687-649-01 | 60687064901 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-649-01) > 1 TABLET in 1 BLISTER PACK (60687-649-11) | 100 blister pack | 2021-08-20 | 0000-00-00 | No | No | Current |